# IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes

Study · id `cardio:ct-nct06118840` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06118840](<https://clinicaltrials.gov/study/NCT06118840>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06118840

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 6450 participants.

## Technical summary

Registry record NCT06118840. Randomized; quadruple masking; primary purpose diagnostic. Start 2024-05-20 (actual); primary completion 2026-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 6450 participants (planned count; ClinicalTrials.gov record NCT06118840, source copy `cardio:ctgov-nct06118840-2025-10-07`, retrieved 2026-11-18)
- Started: 2024-05-20 (actual) (ClinicalTrials.gov record NCT06118840, source copy `cardio:ctgov-nct06118840-2025-10-07`, retrieved 2026-11-18)
- Primary completion: 2026-07 (anticipated) (ClinicalTrials.gov record NCT06118840, source copy `cardio:ctgov-nct06118840-2025-10-07`, retrieved 2026-11-18)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06118840, source copy `cardio:ctgov-nct06118840-2025-10-07`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06118840, source copy `cardio:ctgov-nct06118840-2025-10-07`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06118840-2025-10-07`, retrieved 2026-11-18)

## The registry's words

- Brief title: IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
- Acronym: IDEAL
- Condition: Intracranial Aneurysm
- Condition: CT Angiography
- Condition: Deep Learning
- Condition: Double Bind Interaction
- Intervention (Device): True-AI-integrated intracranial aneurysms diagnosis strategy
- Intervention (Device): Sham-AI-integrated intracranial aneurysms diagnosis strategy
- Lead sponsor: Jinling Hospital, China
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as the lead sponsor: Jinling Hospital, China (`cardio:org-jinling-hospital-china`)

## Provenance

Content hash: 7bf0defb8dceb040aaf194ab52906f2e8bb99e61391bef7063f0669c9a5f651e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
